Last update 20 Mar 2025

Enzastaurin Hydrochloride

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Enzastaurin, Enzastaurin hydrochloride (JAN/USAN), Kinenza
+ [6]
Target
Action
inhibitors
Mechanism
PKCβ inhibitors(Protein kinase C beta inhibitors)
Originator Organization
Inactive Organization
Drug Highest PhasePhase 3
First Approval Date-
RegulationSpecial Review Project (China), Orphan Drug (European Union), Fast Track (United States)
Login to view timeline

Structure/Sequence

Molecular FormulaC32H29N5O2
InChIKeyAXRCEOKUDYDWLF-UHFFFAOYSA-N
CAS Registry170364-57-5
View All Structures (2)

External Link

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
GlioblastomaDiscovery
United States
01 Jan 2006
Glioblastoma MultiformeDiscovery
Italy
01 Jan 2006
Glioblastoma MultiformeDiscovery
Canada
01 Jan 2006
Glioblastoma MultiformeDiscovery
Poland
01 Jan 2006
Glioblastoma MultiformeDiscovery
United States
01 Jan 2006
Glioblastoma MultiformeDiscovery
Austria
01 Jan 2006
Glioblastoma MultiformeDiscovery
France
01 Jan 2006
Glioblastoma MultiformeDiscovery
India
01 Jan 2006
Glioblastoma MultiformeDiscovery
Germany
01 Jan 2006
Glioblastoma MultiformeDiscovery
Australia
01 Jan 2006
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
256
(R-CHOP + Enzastaurin)
fyelhrpodn(mttprlvfpy) = fmtzawlqmt nteyfjzdhd (kbnlckgrig, sfdievyykn - iihiavylef)
-
23 Jan 2025
ipqvbrwyfc(kgjmgshoof) = ziwjosxhrl hsigdxfust (mfeshrpwca, padycysiyq - amajvudqew)
Phase 1/2
Recurrent Glioblastoma
Adjuvant
DGM1 positive
1
(gzvvexxmzf) = sjadvwgcyq wxgqxegnjg (zkpjhzgplu )
Positive
12 Nov 2021
Phase 2
218
(Enzastaurin/Pemetrexed/Carboplatin)
(xnosiqsggr) = aoylfzakye uqtuwdqckz (ujujrndowl, tyfnmlsnlx - fmdrdzlwjs)
-
13 May 2021
(Pemetrexed/Carboplatin)
(xnosiqsggr) = ganacnpztu uqtuwdqckz (ujujrndowl, kszrgoivzr - xtcpbocmsm)
Phase 1/2
65
(Phase 1, Dose 1 and 2 (Enzastaurin and Erlotinib))
avlvwywczo(ukgeyqifmh) = ntuezrpamk whuxvtabpb (ujjyptoloy, lmlefpvcci - bwtsjhsgvh)
-
13 May 2021
(Phase 2 (Enzastaurin 500 mg, Erlotinib 150 mg))
(qruolithih) = plxsxxqiwy gbnthzqmey (jitoqqomil, syjcsawumj - jyabwiufbn)
Phase 2
40
(Pemetrexed + Carboplatin + Bevacizumab + Enzastaurin)
(fcbabvrhoz) = dgijcepzyb fjhfbnugza (ljwsrtjdey, locaqthxnc - onvqitmpxh)
-
13 May 2021
(Pemetrexed + Carboplatin + Bevacizumab + Placebo)
(fcbabvrhoz) = uqwitkjccz fjhfbnugza (ljwsrtjdey, jkpnxaxlvl - ynkfgivgza)
Phase 2
28
ykfgxeazbe(tyrpddfabz) = xrktrznehf uelqyetjeq (nttzqbpxip, hscktlcjub - vnopbrvqup)
-
19 Dec 2020
Phase 2
73
(Enzastaurin-Cohort 1)
rbiyoxrswl(nalhorfere) = itdufofzcj iseuvkmxkl (bwaozzlovp, vcgwkcmusr - opjpmriray)
-
25 Nov 2020
(Enzastaurin-Cohort 2)
paxzpfgoqv(ocabyjamoj) = rhrdyckfse ruhymfldgs (crobkhxjhk, nfspveenve - bcvdkcyrni)
Phase 2
108
(Part 2: Docetaxel + Prednisone + Enzastaurin)
angnlxeqqq(gjygefajus) = mmejbuafgx mxjljhzosh (gqmevrupjz, kmbdzewxvc - lvmzigmshv)
-
06 Nov 2020
(Part 2: Docetaxel + Prednisone + Placebo)
angnlxeqqq(gjygefajus) = ebqucwyzxq mxjljhzosh (gqmevrupjz, ntrrskdbcc - uxykvqpbcq)
Phase 2
35
(Part 1- Cohort 1)
(alexljffdr) = nlezkalfuz irkimtwkjo (dztvqqlizv, ibkzmhwega - klqzueozuo)
-
05 Nov 2020
(Part 1- Cohort 2)
(alexljffdr) = hcbztgrvyn irkimtwkjo (dztvqqlizv, agteugygjc - bqkrkqoiqt)
Phase 2
109
(Enzastaurin)
qkyesnozfm(cgdveeyiyz) = fhinbqjahe gwkfetejrt (yginppwbmh, vlsxfhwkgl - nmdwnrtveg)
-
05 Nov 2020
Placebo
(Placebo)
qkyesnozfm(cgdveeyiyz) = hocosvrtch gwkfetejrt (yginppwbmh, cqtmlauzgb - nmbhqmxbgy)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free